A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer

Vicki E Smith1, Martin L Read, Andrew S Turnell

  • 1School of Clinical and Experimental Medicine, Institute of Biomedical Research, University of Birmingham B15 2TH, UK.

Journal of Cell Science
|August 27, 2009
PubMed

Insights

The proto-oncogene PTTG binding factor (PBF) directly interacts with the sodium iodide symporter (NIS) in thyroid cancer cells. This interaction causes reduced iodide uptake, potentially impacting radioiodine therapy efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Differentiated thyroid cancers often show reduced iodide uptake, limiting radioiodine ablation therapy effectiveness.
  • PTTG binding factor (PBF), a proto-oncogene, is involved in thyroid cancer development and previously shown to inhibit iodide uptake.

Purpose of the Study:

  • To elucidate the mechanism by which PBF modulates sodium iodide symporter (NIS) activity and iodide uptake in vitro.
  • To investigate the direct interaction between PBF and NIS and its functional consequences.

Main Methods:

  • Subcellular localization studies using PBF overexpression.
  • Cell-surface biotinylation assays to assess plasma membrane NIS expression.
  • Coimmunoprecipitation and GST-pull-down assays to confirm NIS-PBF interaction.
  • In vitro iodide uptake studies in rat thyroid FRTL-5 cells.

Main Results:

  • PBF overexpression caused NIS to redistribute from the plasma membrane to intracellular vesicles, colocalizing with CD63.
  • Cell-surface biotinylation confirmed decreased plasma membrane NIS expression upon PBF transfection.
  • Direct binding between NIS and PBF was demonstrated.
  • PBF significantly repressed iodide uptake; deletion mutants lacking intracellular localization lost inhibitory function.

Conclusions:

  • A novel mechanism identified where PBF directly binds NIS, altering its subcellular localization and inhibiting iodide uptake.
  • PBF's role in regulating NIS activity has significant implications for understanding and potentially improving radioiodine ablation therapy in thyroid cancer, where PBF is overexpressed.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...